Effects of low-dose meloxicam in cats with chronic kidney disease

  title={Effects of low-dose meloxicam in cats with chronic kidney disease},
  author={Kate S KuKanich and C George and James K Roush and S Sharp and Giosi Farace and Murthy Yerramilli and Sarah Peterson and Gregory F. Grauer},
  journal={Journal of Feline Medicine and Surgery},
  pages={138 - 148}
Objectives Meloxicam therapy may benefit cats with degenerative joint disease, and retrospective studies suggest it could slow kidney disease progression and increase survival. This study aimed to prospectively evaluate the renal effects of low-dose meloxicam treatment (0.02 mg/kg/day) over 6 months in cats with chronic kidney disease (CKD). Methods Twenty-one cats with stable International Renal Interest Society stage 2 or 3 CKD were recruited and randomized to placebo or meloxicam groups… 

Figures and Tables from this paper

Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease

The aim of this review is to revise the current literature on drug dosing in canine and feline patients with renal impairment, with a special focus on the most commonly used medications to manage chronic kidney disease and possible comorbidities.

Renal biomarkers in cats: A review of the current status in chronic kidney disease

Current knowledge on renal biomarkers in CKD in cats, a field that has progressed substantially over the last 5 years, is summarized.

Is proteinuria a rare condition in apparently healthy and sick cats? A feline practice experience (2007–2018)

It could be concluded that borderline proteinuria and proteinuria were statistically mainly related to CKD in cats during a medical visit for annual health check irrespective of the age.

Urinary Biomarkers of Kidney Disease in Dogs and Cats.

  • M. NabityJ. Hokamp
  • Biology, Medicine
    The Veterinary clinics of North America. Small animal practice
  • 2022

Management of Severe Oral Inflammatory Conditions in Dogs and Cats.

Low dose meloxicam is safe and tolerable when combined with toceranib phosphate in cancer-bearing cats

Low dose meloxicam combined with toceranib is safe and well tolerated in cancer-bearing cats, and the results of this study will guide further phase II/III trials.

The impact of periodontal disease and dental cleaning procedures on serum and urine kidney biomarkers in dogs and cats

The results of this study indicate a link between severity of dental disease, renal tissue injury, and impaired renal function in dogs and cats.

2021 AAFP Feline Senior Care Guidelines

The ‘2021 AAFP Feline Senior Care Guidelines’ are authored by a Task Force of experts in feline clinical medicine and serve as an update and extension of those published in 2009, and introduce the emerging concept of frailty.



Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease.

Proteinuria, anemia, and hyperphosphatemia may reflect more progressive kidney disease and be markers for mechanisms of progression such as tubular protein overload, hypoxia, and nephrocalcinosis.

Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats.

The renal diet evaluated in this study was superior to an adult maintenance diet in minimizing uremic episodes and renalrelated deaths in cats with spontaneous stage 2 or 3 CKD.

Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria.

Plasma creatinine concentration and proteinuria were very highly related to survival and Treated hypertensive cats did not have reduced survival, although systolic blood pressure, together with plasma creat inine concentration was positively related to the magnitude of proteinuria.

Prognostic factors in cats with chronic kidney disease.

B baseline variables, increased plasma creatinine concentration, increased urine protein-to-creatinine ratio (UPC), and increased blood leukocyte count were significantly associated with a shorter renal survival time and were independent risk factors.

Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease

Urinary cytokine measurement may, potentially, be a useful means of assessing intra-renal inflammation, fibrosis and vascular health in cats with CKD.

Comparison of Serum Concentrations of Symmetric Dimethylarginine and Creatinine as Kidney Function Biomarkers in Cats with Chronic Kidney Disease

Using serum SDMA as a biomarker for CKD allows earlier detection of CKD in cats compared with sCr, which may be desirable for initiating renoprotective interventions that slow progression of CKC.

Histomorphometry of Feline Chronic Kidney Disease and Correlation With Markers of Renal Dysfunction

Interstitial fibrosis was the lesion best correlated with the severity of azotemia, hyperphosphatemia, and anemia, whereas higher time-averaged systolic blood pressure was associated with glomerulosclerosis and hyperplastic arteriolosclerosis.

A retrospective analysis of the effects of meloxicam on the longevity of aged cats with and without overt chronic kidney disease

Long-term treatment with oral meloxicam did not appear to reduce the lifespan of cats with pre-existent stable CKD, even for cats in IRIS stages II and III, therefore, to address the need for both quality of life and longevity in cats with chronic painful conditions,Meloxicam should be considered as a part of the therapeutic regimen.

Clinical safety of robenacoxib in feline osteoarthritis: results of a randomized, blinded, placebo-controlled clinical trial

Robenacoxib was well tolerated when administered daily for 1 month in cats with osteoarthritis, including cats with evidence of concurrent CKD, and there was no clinical indication of damage to the gastrointestinal tract, kidney or liver.